Pediatric rare disease drug Qarziba gets green light for coverage
The Health Insurance Review and Assessment Service (HIRA) held its fourth Cancer Disease Review Committee (CDRC) on Wednesday and disclosed the results of its deliberations on the reimbursement standards for anticancer drugs. At the CDRC meeting, Recordati …